Analysis

Mangoceuticals, Inc. (MGRX) Stock Analysis

Mangoceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to MGRX.

websiteMGRX/analysis/MGRX

Mangoceuticals, Inc.

Mangoceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to MGRX.

Stock profile

Ticker

MGRX

Asset type

Stock

Market cap

$5.4M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Mangoceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • MGRX primary listing

Latest Mangoceuticals, Inc. news

Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm...

Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals,” the “Company,” or “MangoRx”), a company focused on

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired V...

Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic B...

Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness produ...

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatme...

Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Comp...

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

DALLAS, TX, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company”), a company focused on developing, marketing, and selling a variety of health an...

Research sections

Valuation

Review valuation context for Mangoceuticals, Inc..

Future growth

Review future growth context for Mangoceuticals, Inc..

Past performance

Review past performance context for Mangoceuticals, Inc..

Financial health

Review financial health context for Mangoceuticals, Inc..

Dividend

Review dividend context for Mangoceuticals, Inc..

Management

Review management context for Mangoceuticals, Inc..

Ownership

Review ownership context for Mangoceuticals, Inc..

Other information

Review other information context for Mangoceuticals, Inc..

Community

Review community context for Mangoceuticals, Inc..